Geva, Michal
Gershoni-Emek, Noga
Naia, Luana
Ly, Philip
Mota, Sandra
Rego, Ana Cristina
Hayden, Michael R.
Levin, Leonard A.
Funding for this research was provided by:
Prilenia
Article History
Received: 16 June 2021
Accepted: 20 October 2021
First Online: 9 November 2021
Competing interests
: MG and NGE are employees of Prilenia Neurotherapeutics, Ltd, a subsidiary of Prilenia Therapeutics, BV. MRH is CEO of Prilenia Neurotherapeutics, BV. LAL is an advisor for Prilenia Therapeutics, Ltd. LN, PL, SM and ACR report no competing interests.